129 related articles for article (PubMed ID: 8520490)
1. Molecular model of the N-terminal receptor-binding domain of the human CD6 ligand ALCAM.
Bajorath J; Bowen MA; Aruffo A
Protein Sci; 1995 Aug; 4(8):1644-7. PubMed ID: 8520490
[TBL] [Abstract][Full Text] [Related]
2. Recognition of diverse proteins by members of the immunoglobulin superfamily: delineation of the receptor binding site in the human CD6 ligand ALCAM.
Skonier JE; Bowen MA; Emswiler J; Aruffo A; Bajorath J
Biochemistry; 1996 Sep; 35(38):12287-91. PubMed ID: 8823162
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of the CD6 binding site in activated leukocyte cell adhesion molecule.
Skonier JE; Bowen MA; Emswiler J; Aruffo A; Bajorath J
Biochemistry; 1996 Nov; 35(47):14743-8. PubMed ID: 8942635
[TBL] [Abstract][Full Text] [Related]
4. Characterization of mouse ALCAM (CD166): the CD6-binding domain is conserved in different homologs and mediates cross-species binding.
Bowen MA; Bajorath J; D'Egidio M; Whitney GS; Palmer D; Kobarg J; Starling GC; Siadak AW; Aruffo A
Eur J Immunol; 1997 Jun; 27(6):1469-78. PubMed ID: 9209500
[TBL] [Abstract][Full Text] [Related]
5. Identification of residues in CD6 which are critical for ligand binding.
Bodian DL; Skonier JE; Bowen MA; Neubauer M; Siadak AW; Aruffo A; Bajorath J
Biochemistry; 1997 Mar; 36(9):2637-41. PubMed ID: 9054570
[TBL] [Abstract][Full Text] [Related]
6. CD6 recognizes the neural adhesion molecule BEN.
Skonier JE; Bowen MA; Aruffo A; Bajorath J
Protein Sci; 1997 Aug; 6(8):1768-70. PubMed ID: 9260290
[TBL] [Abstract][Full Text] [Related]
7. Cell surface receptors and their ligands: in vitro analysis of CD6-CD166 interactions.
Bowen MA; Aruffo AA; Bajorath J
Proteins; 2000 Aug; 40(3):420-8. PubMed ID: 10861932
[TBL] [Abstract][Full Text] [Related]
8. The amino-terminal immunoglobulin-like domain of activated leukocyte cell adhesion molecule binds specifically to the membrane-proximal scavenger receptor cysteine-rich domain of CD6 with a 1:1 stoichiometry.
Bowen MA; Bajorath J; Siadak AW; Modrell B; Malacko AR; Marquardt H; Nadler SG; Aruffo A
J Biol Chem; 1996 Jul; 271(29):17390-6. PubMed ID: 8663238
[TBL] [Abstract][Full Text] [Related]
9. The membrane-proximal scavenger receptor cysteine-rich domain of CD6 contains the activated leukocyte cell adhesion molecule binding site.
Whitney GS; Starling GC; Bowen MA; Modrell B; Siadak AW; Aruffo A
J Biol Chem; 1995 Aug; 270(31):18187-90. PubMed ID: 7543097
[TBL] [Abstract][Full Text] [Related]
10. Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand.
Bowen MA; Patel DD; Li X; Modrell B; Malacko AR; Wang WC; Marquardt H; Neubauer M; Pesando JM; Francke U
J Exp Med; 1995 Jun; 181(6):2213-20. PubMed ID: 7760007
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of the CD6 ligand binding domain.
Skonier JE; Bodian DL; Emswiler J; Bowen MA; Aruffo A; Bajorath J
Protein Eng; 1997 Aug; 10(8):943-7. PubMed ID: 9415444
[TBL] [Abstract][Full Text] [Related]
12. Characterization of mouse CD6 with novel monoclonal antibodies which enhance the allogeneic mixed leukocyte reaction.
Starling GC; Whitney GS; Siadak AW; Llewellyn MB; Bowen MA; Farr AG; Aruffo AA
Eur J Immunol; 1996 Apr; 26(4):738-46. PubMed ID: 8625962
[TBL] [Abstract][Full Text] [Related]
13. ALCAM/CD166: cancer-related issues.
Weidle UH; Eggle D; Klostermann S; Swart GW
Cancer Genomics Proteomics; 2010; 7(5):231-43. PubMed ID: 20952758
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cell surface antigen SB-10 corresponds to activated leukocyte cell adhesion molecule and is involved in osteogenic differentiation.
Bruder SP; Ricalton NS; Boynton RE; Connolly TJ; Jaiswal N; Zaia J; Barry FP
J Bone Miner Res; 1998 Apr; 13(4):655-63. PubMed ID: 9556065
[TBL] [Abstract][Full Text] [Related]
15. MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule).
Degen WG; van Kempen LC; Gijzen EG; van Groningen JJ; van Kooyk Y; Bloemers HP; Swart GW
Am J Pathol; 1998 Mar; 152(3):805-13. PubMed ID: 9502422
[TBL] [Abstract][Full Text] [Related]
16. Distinct kinetic and mechanical properties govern ALCAM-mediated interactions as shown by single-molecule force spectroscopy.
Te Riet J; Zimmerman AW; Cambi A; Joosten B; Speller S; Torensma R; van Leeuwen FN; Figdor CG; de Lange F
J Cell Sci; 2007 Nov; 120(Pt 22):3965-76. PubMed ID: 17971418
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure at 2.8 A resolution of a soluble form of the cell adhesion molecule CD2.
Jones EY; Davis SJ; Williams AF; Harlos K; Stuart DI
Nature; 1992 Nov; 360(6401):232-9. PubMed ID: 1279440
[TBL] [Abstract][Full Text] [Related]
18. Frontline: Optimal T cell activation requires the engagement of CD6 and CD166.
Hassan NJ; Barclay AN; Brown MH
Eur J Immunol; 2004 Apr; 34(4):930-40. PubMed ID: 15048703
[TBL] [Abstract][Full Text] [Related]
19. Towards the definition of a chimpanzee and human conserved CD6 domain 1 epitope recognized by T1 monoclonal antibody.
Alonso R; Huerta V; de Leon J; Piedra P; Puchades Y; Guirola O; Chinea G; Montero E
Hybridoma (Larchmt); 2008 Aug; 27(4):291-301. PubMed ID: 18707547
[TBL] [Abstract][Full Text] [Related]
20. Tissue distribution of CD6 and CD6 ligand in cattle: expression of the CD6 ligand (CD166) in the autonomic nervous system of cattle and the human.
Konno A; Ahn JS; Kitamura H; Hamilton MJ; Gebe JA; Aruffo A; Davis WC
J Leukoc Biol; 2001 Jun; 69(6):944-50. PubMed ID: 11404380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
